- Home
- / Pear Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Pear Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2023-06-20
Market Capitalization
$4.2 M
2023-06-20
Revenue
$12.7 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|
| Revenue | 9.4M | 4.2M | 12.7M |
| Cost of goods sold | 1.7M | 5.2M | 8.2M |
| Gross profit | 7.7M | (1.0M) | 4.5M |
| Gross profit margin, % | 81.7% | -24.4% | |
| General and administrative expense | 56.2M | 67.6M | 79.6M |
| Operating expense total | 84.3M | 104.7M | 127.9M |
| EBIT | (76.6M) | (105.7M) | (123.3M) |
| EBIT margin, % | -816.8% | -2511.5% | |
| Interest expense | 2.6M | 4.1M | 3.9M |
| Net Income | (97.0M) | (65.1M) | (75.5M) |
| EPS | (7.3) | (0.6) |